At BPI in Boston this September we were lucky enough to get to talk to Ryan MacDougall of Lonza and to hear about the BioPhorum group that he was representing at the conference.
What is the BioPhorum group?
Growing from an end-user group in 2008, BioPhorum now comprises over 135 manufacturers and suppliers deploying their top 6000 leaders and subject matter experts to work in nine focused Phorums, articulating the industry’s technology roadmap, defining the supply partner practices of the future, and developing and adopting best practices in drug substance, fill finish, process development and manufacturing IT.
“Our mission is to create an environment where the global biopharmaceutical and device industry can collaborate and accelerate its rate of progress – for the benefit of all.”
Ryan MacDougall told us some more about:
- Multi angle light scattering (MALS) – what it is and how it’s used
- what has been done so far and what is the next step
- the developments in downstream analytics that have made an enormous difference over the last years.
About Ryan MacDougall
Ryan MacDougall is a Lead Scientist in the Process Science and Technology Biologics R&D group at Lonza. He has over 17 years of industry experience ranging from manufacturing to process development and MSAT roles, with a primary focus on the downstream process. In his current position, he leads a group of scientists evaluating inline PAT to enable improved bioprocess monitoring and control.
